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Purpose: Primary open-angle glaucoma (POAG) is a common but complex disease with a strong genetic component.
Notably, few genes have been robustly associated with POAG. An obvious group of genes to test as susceptibility factors
for POAG are the developmental genes forkhead box C1 (FOXC1), transforming growth factor-beta 2 (TGFβ2), and bone
morphogenic protein 4 (BMP4). These genes are known to play important roles in the normal morphogenesis of the anterior
segment and/or have been implicated in intra-ocular pressure (IOP) regulation and trabecular meshwork function. This
study investigates the role of FOXC1, TGFβ2, and BMP4 in POAG.
Methods: The contribution of common genetic variation at the FOXC1, TGFβ2, and BMP4 loci to risk of POAG was
investigated in a case-control association study in 330 British Caucasian individuals comprised of 272 high-tension
glaucoma (HTG) and 58 ocular hypertension (OHT), and 276 matched controls.
Results: All the single nucleotide polymorphisms (SNPs) were in Hardy–Weinberg equilibrium and genotyping success
rate was >92% for all SNPs. With the exception of a weak association between the BMP4 tagging SNP rs2761884 and
the combined patient group HTG+OHT that did not withstand permutation testing (uncorrected p=0.0400, corrected
p=0.1320), no associations (p<0.05) were identified between the patient groups (HTG and OHT) and FOXC1, TGFβ2,
and BMP4 alleles and haplotypes compared to the control group.
Conclusions: This is the first association analysis of FOXC1, TGFβ2, and BMP4 and POAG. These genes were selected
as candidate genes for POAG because of their biologic roles. No significant associations were identified between
FOXC1, TGFβ2, and BMP4 alleles and haplotypes and POAG. The lack of association suggests that common variation
in these genes do not have a significant role in the pathogenesis of POAG among British Caucasian subjects.
Glaucoma is a complex heterogeneous disorder
characterized by an optic neuropathy in which progressive
degeneration of retinal ganglion cells leads to excavation of
the optic nerve head and to visual field loss. It is a major cause
of visual impairment and blindness worldwide affecting
approximately 67 million people [1]. Primary open-angle
glaucoma (POAG), the most common form of glaucoma, has
an estimated prevalence of 1.2% for the age group 40 to 89
years in the white UK population [2]. POAG is predominately
composed of high-tension glaucoma, where the intraocular
pressure (IOP) is raised (IOP >21 mmHg). Normal-tension
glaucoma (NTG), which is another important but less
common subgroup of POAG, is an optic neuropathy similar
to HTG but the IOP levels are within the statistically normal
range (IOP ≤21 mmHg). On the other hand, individuals with
ocular hypertension (OHT) have raised IOP without clinical
signs of glaucomatous optic neuropathy; however, OHT is an
important risk factor for POAG, and 10% will convert to
POAG over a 10-year period [3].
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Although the proportion of genetically attributable cases
of POAG is unknown, there is increasing evidence to suggest
POAG has a significant heritable basis. Population-based
studies have shown that a positive family history is an
important risk factor for POAG. The relative risk of
developing POAG among individuals with a positive family
history varies from 3 to 10-fold [4,5]. Further evidence that
genetic factors are important is supported by twin studies
which have shown a higher degree of concordance among
monozygotic twin [6,7]. In particular, Gottfredsdottir et al.
[6] showed the concordance of open angle glaucoma in
monozygotic twin pairs was significantly higher at 98%
compared to their spouses (70%). Moreover, the prevalence
of POAG is highest in black populations and lowest in
northern Asian populations; these ethnic differences may be
attributable to genetics among other factors [8]. Genetic
linkage studies among rare pedigrees with Mendelian patterns
of adult-onset POAG inheritance have identified 14 genetic
loci (GLC1A-N) [9-19]. However, only 3 genes (myocilin,
trabecular meshwork inducible glucocorticoid response
[MYOC], optineurin [OPTN], and WD repeat domain 36
[WDR36]) have shown to be robustly associated with POAG
in the general population. Furthermore, only MYOC (GLC1A)
is established as directly causative, mutations of which
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account for 5% of POAG, while due to conflicting results the
exact roles of OPTN (GLC1E) and WDR36 (GLC1G) in
POAG remain uncertain [20,21]. A recent genome-wide
association study involving 590 affected individuals with
advanced POAG and 3,956 controls, has identified
susceptible loci at transmembrane and coiled-coil domain-
containing protein 1 (TMCO1) and CDKN2B antisense RNA
1 (non-protein coding; CDKN2B-AS1) for POAG [22]. Based
on current knowledge, it is probable that POAG is a
genetically heterogeneous disorder caused by the interaction
between several genetic and environmental factors.
Genes that cause developmental glaucoma [23], with the
exception of the cytochrome P450, family 1, subfamily B,
polypeptide 1 (CYP1B1) and LIM homeobox transcription
factor 1, beta (LMX1B) genes, have yet to be assessed as
genetic susceptibility factors for POAG. CYP1B1 causes
primary congenital glaucoma and is also involved in cases of
juvenile open-angle glaucoma [24]. A recent study has
implicated a CYP1B1 polymorphism as a susceptibility factor
for POAG [25]. LMX1B mutations, on the other hand, cause
dominantly-inherited Nail-Patella Syndrome (NPS; OMIM
161200) in which approximately 33% of patients develop
glaucoma [26]. More importantly, LMX1B haplotypes have
shown to influence susceptibility to POAG [27].
Developmental glaucoma refers to glaucomas that are
associated with developmental malformations of the anterior
segment of the eye [28]. Anterior segment dysgenesis (ASD)
may lead to incomplete development, or dysfunction, of the
structures that form the aqueous drainage pathway, and can
result in IOP elevation secondary to aqueous outflow
obstruction, predisposing to glaucoma [23]. Existing studies
indicate that developmental glaucoma genes forkhead box C1
(FOXC1), transforming growth factor-beta 2 (TGFβ2), and
bone morphogenic protein 4 (BMP4) are strong candidate
genes for POAG susceptibility. Foxc1 is expressed in the
developing trabecular meshwork (TM) [29] whereas TGFβ2
and BMP4 are expressed in the adult human TM [30,31]. All
of these genes cause developmental malformation of the
anterior segment [29,32,33]. The essential role of these
developmental glaucoma genes for the development of the
anterior segment and in the development of TM implies that
FOXC1,TGFβ2, and BMP4 are crucial for the normal
development of drainage structures and preservation of
normal IOP. This idea is supported by targeted heterozygous
mutation in animal models resulting in malformation of the
drainage structures [29,32,33] with a high incidence of
glaucoma ranging from 40%–75% or above [33,34].
Elevated levels of TGFβ2 have been found in POAG
patients. In addition, studies have shown that raised IOP in
POAG is as a result of increased resistance to aqueous outflow
[35] and this is associated with biochemical and
morphological changes in the TM [36]. There is an
accumulation of extracellular matrix (ECM) in the TM of
glaucoma patients, and this may be as a result of disruption of
the balance between ECM deposition and degradation [36].
In vitro studies have shown that TGFβ2 and BMP4 act in
concert to maintain a balance between ECM deposition and
degradation, and may play an important role in glaucoma
pathogenesis through mis-regulation of ECM synthesis and
cross-linkage of ECM components of the TM [30].
Since Foxc1 is expressed in the developing embryonic
TM [29], mutations or altered expression of FOXC1 could
interfere with normal function of the tissue and lead to
increased risk of glaucoma. Although expression of FOXC1
is yet to be studied in adults, it is highly possible that continued
expression of the abnormal gene product (from age-related,
subclinical mutations) throughout life, or altered levels of
expression of FOXC1 could interfere with normal function of
the TM, thereby leading to increased risk of glaucoma through
the effects of raised IOP. This notion is supported by the fact
that glaucoma associated with mutations in the developmental
glaucoma genes can present at any time from birth to
adulthood, and in some instances above 70 years of age [37].
Furthermore, in some affected family members with
glaucoma as a result of FOXC1 mutations, the anterior
segment malformation may be very subtle, and easily missed
in clinical examination [37,38], a feature more in keeping with
POAG. In addition, the risk of developing glaucoma is not
related to the severity of the phenotype [37], suggesting that
subtle dysfunction of the angle drainage structures may be
contributing toward glaucoma [39].
It is thus plausible that these developmental glaucoma
genes contribute to age-related open angle glaucoma, where
the ocular drainage structures have abnormalities that are not
clinically visible but which cause dysfunction with age. We
hypothesize that sub-clinical mutations/polymorphisms in
FOXC1, TGFβ2, and BMP4 may produce subtle and
undetected abnormalities in anterior segment structure and
function, which predispose to glaucomatous optic neuropathy
through the effects of raised IOP and may be a significant
susceptibility factor for the development of OHT and POAG.
In this study, we assess whether variant alleles of
FOXC1, TGFβ2, and BMP4 play a role in the general
population. A case-control genetic association study was
performed to compare the prevalence of FOXC1, TGFβ2, and
BMP4 tagging single nucleotide polymorphisms (tSNPs) in
three groups, HTG, OHT, and a normal control group.
Haplotypes in FOXC1, TGFβ2, and BMP4 were identified and
their prevalence assessed in patients with glaucomatous optic
neuropathy (HTG patients) and in patients with raised IOP
(HTG and OHT patients).
METHODS
Recruitment of patients: All of the participating subjects were
recruited from glaucoma outpatient clinics at the Sunderland
Eye Infirmary in the North-East of England, UK, a secondary
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Figure 1. Linkage disequilibrium plot
of BMP4 region HapMap SNPs. A: The
relative position of the 5 tSNPs in
BMP4 spanning a region of 17,443 bp
(Chr14: 53483882–53501325). Four
coding exons are indicated as solid
boxes and numbered accordingly.
Untranslated exons are shown as open
boxes. B: Diagram of block structure of
BMP4 generated using Haploview v.
4.0. LD plots were identified by strong
LD. Depth of red/pink color indicates
the computed pairwise D' value; deeper
pink indicates a higher D' value. C: The
selected tSNPs and estimated haplotype
frequencies in the two major haplotype
blocks are shown. Marker numbers and
arrows above the haplotypes indicate
tSNPs. The frequency of each haplotype
within a block is given to the right of the
haplotype. The thickness of the lines
connecting the haplotypes across blocks
represents the relative frequency (i.e.,
high [thick] versus low [thin]) with
which a given haplotype is associated
with the haplotype in the neighboring
block.
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ophthalmology referral center. The research followed the
tenets of the Declaration of Helsinki. Informed consent was
obtained from all participants after the nature and possible
consequences of the study were explained. The study had
Local Research Ethics Committee approval. A cohort of HTG
cases (n=272), and unrelated controls (n=276) matched for
ethnicity, age and sex were recruited to the study. Cases with
OHT (n=58) were also collected. All cases (n=330) and
controls were of British Caucasian descent.
Control participants, either accompanying spouses or
friends of individuals with glaucoma, were recruited
randomly. All controls underwent a complete ophthalmic
examination to exclude individuals with glaucoma from the
control group, and were confirmed to have no visual
complaints and IOP of <22 mmHg with a normal disc
appearance. Individuals with a family history of glaucoma
were excluded.
All case subjects underwent a complete ophthalmic
examination as previously described (Park et al. [27])
including best visual acuity, and visual field testing using a
Humphrey SITA standard 24–2 perimetry (Carl Zeiss Meditec
AG, Jena, Germany), slit lamp examination of the anterior
segment (including gonioscopy), measurement of IOP by
Goldmann applanation tonometer, posterior segment
examination of the retina and optic disc following pupil
dilation and measurement of the cup-disc ratio (CDR). The
clinical diagnosis (including assessment of visual fields) was
made by the same consultant with a special interest in
glaucoma and experience in anterior segment phenotyping.
This ensured exclusion of individuals with glaucoma from the
Figure 2. Linkage disequilibrium plot
of TGFβ2 region HapMap SNPs. A: The
relative position of the remaining 19
tSNPs in TGFβ2 (labeled above with the
respective haplotype) spanning a region
of 104,437 bp (Chr1: 216582933–
216687370). Eight coding exons are
indicated as solid boxes and numbered
accordingly. Untranslated exons are
shown as open boxes. B: Diagram of
block structure of TGFβ2 generated
using Haploview v.4.0.LD plots were
identified by strong LD. Depth of red/
pink color indicates the computed
pairwise D' value; deeper pink indicates
a higher D' value. C: The selected tSNPs
and estimated haplotype frequencies in
the four major haplotype blocks (1–4)
are shown. Marker numbers above the
haplotypes indicate tSNPs. The
frequency of each haplotype within a
block is given to the right of the
haplotype. The thickness of the lines
connecting the haplotypes across blocks
represents the relative frequency (i.e.,
high [thick] versus low [thin]) with
which a given haplotype is associated
with the haplotype in the neighboring
block.
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control group and made certain that cases were correctly
classified either as HTG and OHT. Central corneal thickness
(CCT) data was not collected for the cases and controls in the
current study since a pachymeter was not available at the time
when this study was performed. Adult individuals with a
Figure 3. Linkage disequilibrium plot
of FOXC1 region HapMap SNPs. A:
The relative position of the remaining 4
tSNPs (labeled above with the
respective haplotype) spanning a region
of 14,587 bp in FOXC1
(Chr6:1543941–1558528). The coding
exon is indicated as a solid box. B:
Diagram of block structure of FOXC1
generated using Haploview v.4.0
showing absence of common haplotype
due to low LD between tSNPs. Depth of
red/pink color indicates the computed
pairwise D' value; deeper pink indicates
a higher D' value.
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diagnosis of HTG or OHT after the age of 40 years were
enrolled based on the following clinical criteria:
Presence of glaucomatous optic neuropathy (defined by
loss of neuroretinal rim) with compatible and reproducible
visual field loss for HTG, and absence of detectable
glaucomatous damage or field loss for OHT. All of the visual
field tests showed reproducible field defects that were
compatible with the degree of glaucomatous cupping of the
optic nerve head (defined by loss of neuroretinal rim), and
were ensured to have a satisfactory reliability score of ≤20%
fixation loss, false positive of ≤33% and/or false negative of
≤33%;
Open drainage angles on gonioscopy;
IOP consistently ≥22 mmHg on diurnal testing for HTG
and OHT. To be certain that the participants were correctly
assigned to the appropriate case groups, individuals with
borderline IOPs (21–23 mmHg) were excluded from this
study;
Absence of a secondary cause for glaucomatous optic
neuropathy;
Absence of non-glaucomatous field losses and disc
changes (i.e., high myopia).
Selection and analysis of single nucleotide polymorphisms:
We employed a tagging single nucleotide polymorphism
approach to screen FOXC1, TGFβ2, and BMP4 genes
including 10 kb of upstream and downstream flanking region
in patient and control groups using tSNPs selected from the
HapMap database (HapMap Data Release #22/Phase II Apr
2007; Centre d'Etude du Polymorphisme Humain [CEPH]
population). Genotypes of 90 CEU The Sequenom iPLEXTM
Assay MassARRAY® (Sequenom, San Diego, CA) was used
for high-throughput SNP genotyping (details of primer
information used for SNP genotyping provided in Appendix
1). Allele frequencies for each SNP were tested for agreement
with Hardy–Weinberg expectations (p>0.05) using a χ2
goodness-of-fit test.
A total of 5 tSNPs for BMP4 spanning a region of 15,272
bp (including the 4,814 bp BMP4 gene), 19 tSNPs for
TGFβ2, spanning a region of 98,075 bp (including the 95,108
bp TGFβ2 gene), and 4 tSNPs for FOXC1 spanning a region
of 12,012 bp (including the 1,661 bp FOXC1 gene) were
selected from the HapMap database and genotyped in all
individuals (Figure 1, Figure 2, and Figure 3).
LD and haplotype structure of the FOXC1, TGFβ2, and
BMP4 genomic region: Haplotypes were inferred using
Haploview v.4.0, and associations between tSNP or haplotype
and glaucoma were investigated. The method of Gabriel et al.
[40], as implemented in Haploview, was used to construct LD
blocks from tSNPs with minor allele frequencies (MAF) ≥5%.
LD between tSNPs was measured by the pairwise D' statistic
and the LD structure was examined using the 80% confidence
bounds of D' to define sites of historical recombination
between tSNPs.
Haplotypes were constructed from genotype data in the
full-size case-control panel within blocks by using an
accelerated expectation-maximization algorithm method
[41]. In each haplotype block, common haplotypes with
frequencies ≥1% were inferred that accounted for >98% of the
chromosomes. Differences in genotype and haplotype
frequencies between cases and controls were determined
using a χ2 distribution with 2 degrees of freedom. Permutation
testing was performed to calculate corrected p-values for
multiple testing with 1,000 simulations. Odds ratios (ORs)
were calculated using THESIAS v.3.1 with 95% confidence
intervals (CIs) for each genotype with the respective wild type
as the reference. Thesias is based on the maximum likelihood
model described in Tregouet et al. [42].
Using the Stata built-in power and sample size functions
(Stata Statistical Software: Release 8.0; Stata Corporation,
College Station, TX), a power of 80% was estimated using the
sample size of 276 controls and 330 cases, to identify a
difference in genotype and allele frequency between 10%–
18% at a significance level of p<0.05 between the controls and
cases.
RESULTS
Among the cases, 272 (74.3%) were classified as HTG, and
58 (15.6%) as OHT (Table 1). All tSNPs (Figure 1, Figure 2,
and Figure 3) conformed to Hardy–Weinberg equilibrium and
the genotyping success rate varied from 92.0% and 99.0%.
The pairwise LD matrix revealed 2 main haplotype blocks for
BMP4 (Figure 1) and 4 haplotype blocks for TGFβ2 (Figure
2). Haplotype analysis of FOXC1 revealed no common
haplotype between patients and variants of FOXC1 (Figure 3)
due to lack of LD between SNPs.
Lack of association between SNPs in TGFβ2, BMP4, and
FOXC1 and POAG: The allele frequencies of the 19 tSNPs in
TGFβ2, 5 tSNPs in BMP4 and 4 tSNPs in FOXC1 between
the 3 separate case groups (HTG, OHT, HTG+OHT) and the
controls were assessed. No significant associations were
found between TGFβ2, BMP4, and FOXC1 and glaucoma
(Table 2 [A], Table 3 [A], Table 4), except between the
combined group HTG+OHT and BMP4 (Table 3 [A]) where
there was a weak association which did not withstand
permutation testing (uncorrected p=0.040, corrected
p=0.1320, OR 1.26). In addition, these tSNPs were analyzed
under 3 different genetic models (dominant, co-dominant and
recessive models) and no significant associations were
identified (data not shown).
Absence of association between haplotypes in TGFβ2 and
BMP4 and HTG: The difference in the distribution of all
common haplotypes in TGFβ2 and BMP4 (see Table 2 [B]
and Table 3 [B]) between individuals with HTG and controls
was assessed (but not for FOXC1 as common haplotypes were
not present) and no significant haplotype associations were
identified for each haplotype blocks. The absence of common
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haplotypes between patients and FOXC1 can be explained by
the small size of the FOXC1 gene (3,447 bp), which makes it
less likely that haplotype blocks are present in such a small
region.
Absence of association between haplotypes in TGFβ2 and
BMP4, and raised IOP (HTG+OHT): Here, assessment for
possible common haplotype associations between combined
raised IOP patient group (HTG+OHT) and the controls were
performed for TGFβ2 and BMP4 (see Table 2 [C] and Table
3 [C]) but not for FOXC1 as common haplotypes were not
present and no significant haplotype effects for each
haplotype block were found.
DISCUSSION
Despite recent progress in identifying genes associated with
glaucoma, the contribution of genetics to the pathogenesis of
POAG continues to remain unclear. Given the relatively high
prevalence of POAG within the normal population, and the
fact that it is amendable to treatment when detected early,
identification of genetic risk factors would offer the prospect
of early POAG diagnosis, in addition to the tailoring of
appropriate treatments to those who would be most likely to
benefit. However, such screening programs are currently
limited by the paucity of the identified causative genes [43]
and identification of the most significant disease-associated
alleles in different populations is of paramount importance.
Recent work has started to investigate whether analysis
of genetic risk in glaucoma can be progressed through the
investigation of individual quantitative traits underlying
disease risk- IOP, optic nerve cupping as measured by CDR,
and CCT. For example, a recent study showed that both CDR
and IOP have genetic components that correlate with POAG
[44]. Wirtz et al. [15] proposed that searching for genes
influencing POAG phenotype components may increase the
power to dissect the genetic architecture of POAG. The
question of whether the genetic etiology of POAG is
determined by a large number of rare variants with major
effects on the disease risk (rare variant, common disease
hypothesis) or whether there are multiple common variants
underlying the disease (common variant, common disease
hypothesis) is also being addressed in new studies [45]. For
example, based on a genome wide SNP analysis of a large
cohort, Ramdas et al. [45] proposed a polygenic model for
CDR.
Genes in which mutation causes anterior segment angle
anomalies and glaucoma are strong candidates for glaucoma
susceptibility and may contribute to glaucoma more
frequently than expected, and possibly play an important role
in the common form of POAG. In this study three candidate
genes TGFβ2, BMP4, and FOXC1 were examined. Selection
of these candidates was based existing knowledge of their
function in the anterior segment.
In this study, despite the evidence that the candidate genes
are involved in glaucoma disease pathways no significant
associations were identified between TGFβ2, BMP4, and
FOXC1 alleles and haplotypes and POAG in a population of
patients and controls recruited form the North East of
England. This represents the first association analysis of
TGFβ2, BMP4, and FOXC1; the lack of association of
common polymorphism does not provide evidence in support
of the hypothesis that these genes play a significant genetic
role in the pathogenesis of glaucoma among white British
subjects.
A lack of association, however, should be interpreted
with caution unless proven by investigating a substantially
larger sample of the population. This is because of the small
possibility of such results being caused by a false-negative
error, which is confounded by the small size of the OHT sub-
group. The key determinant of quality in an association study
is the sample size since the power to detect an association
depends partly on this as well as the size of the effect. If a
study with negative results has insufficient power, an
association is unlikely to be significant as there is a higher
chance that it is a falsely negative result. For this study, with
a sample size of 276 controls and 330 cases, an adequate study
power of 80% was achieved if a difference in genotype and
allele frequency was 10%–18% between controls and cases at
a significance level of p<0.05. However, if the individual
subgroups are considered, the OHT group (n=58) was clearly
under-represented, despite being adequate to produce a robust
result as being part of the whole cohort. In addition, the results
obtained from this study reflect only one ethnic group (in this
TABLE 1. COMPARISON OF AGE, SEX, MEAN CDR AND MEAN IOP BETWEEN HTG, OHT, HTG+OHT GROUP (WITH RAISED IOP) AND THE CONTROL GROUP.
Characteristic OHT HTG Controls Cases combined
(OHT+HTG)
p1
N 58 272 276 330
Age (SD) *65.19 (11.494) 71.17 (10.448) 70.76 (9.313) 70.12 (10.863) 0.437
Sex % Male 41.4 *54.4 42.8 52.1 0.022
Mean CDR (SD) 0.3629 (0.138) *0.7175 (0.182) 0.2120 (0.231) 0.6552 (0.221) <0.0001
Mean IOP (SD) *27.16 (4.021) *29.13 (5.506) 15.45 (2.352) 28.79 (5.326) <0.0001
* indicates significant difference (p<0.05) between controls and the separate case groups (HTG, OHT). p1 indicates significant
difference between controls and the HTG+OHT group. p values were calculated using independent samples t-test, except a χ2
test was used for sex, using SPSS, version 15 (SPSS Inc., Chicago, IL).
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TABLE 2. NO SIGNIFICANT ASSOCIATIONS IDENTIFIED BETWEEN TGFΒ2 SNPS AND HAPLOTYPES AND POAG.
A
SNP ID Allele Phenotype Case counts
(%)
Control counts
(%)
χ2 Uncorrected p-
value
rs10495098 G HTG 297 (56.2) 311 (56.8) 0.03 0.8619
 G OHT 72 (65.5) 311 (56.8) 2.85 0.0912
 G HTG+OHT 370 (57.8) 311 (56.8) 0.14 0.7125
rs17047682 G HTG 39 (7.4) 31 (5.7) 1.32 0.2502
 G OHT 5 (4.5) 31 (5.7) 0.22 0.6399
 G HTG+OHT 44 (6.9) 31 (5.7) 0.77 0.3819
rs2799097 A HTG 69 (13.3) 80 (15.0) 0.67 0.4108
 A OHT 17 (16.0) 80 (15.0) 0.07 0.7934
 A HTG+OHT 86 (13.7) 80 (15.0) 4.21 0.0601
rs17047703 A HTG 140 (26.8) 127 (23.2) 1.89 0.1685
 A OHT 21 (19.1) 127 (23.2) 0.72 0.3956
 A HTG+OHT 161 (25.5) 127 (23.2) 0.84 0.3591
rs17558745 T HTG 191 (36.6) 169 (31.2) 3.47 0.0623
 T OHT 30 (28.0) 169 (31.2) 0.01 0.9134
 T HTG+OHT 221 (35.1) 169 (31.2) 1.99 0.1579
rs2796817 G HTG 70 (13.2) 83 (15.1) 0.78 0.3749
 G OHT 19 (17.3) 83 (15.1) 0.33 0.5633
 G HTG+OHT 89 (13.9) 83 (15.1) 0.34 0.5623
rs3892225 G HTG 119 (22.5) 106 (19.3) 1.74 0.1873
 G OHT 20 (18.2) 106 (19.3) 0.07 0.7904
 G HTG+OHT 139 (21.8) 106 (19.3) 1.14 0.2855
rs2009112 C HTG 215 (40.6) 222 (40.4) 0.01 0.946
 C OHT 42 (38.2) 222 (40.4) 0.18 0.6698
 C HTG+OHT 257 (40.2) 222 (40.4) 0.01 0.9420
rs10482751 C HTG 145 (27.6) 153 (27.8) 0.01 0.9265
 C OHT 30 (27.3) 153 (27.8) 0.01 0.9071
 C HTG+OHT 175 (27.5) 153 (27.8) 0.01 0.9076
rs2027566 C HTG 167 (31.5) 172 (31.4) 0.00 0.9654
 C OHT 35 (31.8) 172 (31.4) 0.01 0.9292
 C HTG+OHT 202 (31.6) 172 (31.4) 0.00 0.9482
rs2027567 G HTG 116 (22.1) 124 (22.5) 0.04 0.8463
 G OHT 22 (20.0) 124 (22.5) 0.35 0.5571
 G HTG+OHT 138 (21.7) 124 (22.5) 0.12 0.7258
rs2796814 G HTG 132 (25.1) 118 (21.6) 1.82 0.1776
 G OHT 26 (23.6) 118 (21.6) 0.22 0.6398
 G HTG+OHT 158 (24.8) 118 (21.6) 1.71 0.1905
rs947712 T HTG 185 (35.6) 191 (35.1) 0.03 0.8735
 T OHT 41 (37.3) 191 (35.1) 0.19 0.6655
 T HTG+OHT 226 (35.9) 191 (35.1) 0.07 0.7854
rs10779329 C HTG 124 (23.6) 119 (21.7) 0.53 0.4667
 C OHT 31 (28.2) 119 (21.7) 2.18 0.1401
 C HTG+OHT 155 (24.4) 119 (21.7) 1.17 0.2800
rs1317681 A HTG 84 (15.9) 89 (16.4) 0.04 0.8409
 A OHT 20 (18.5) 89 (16.4) 0.30 0.5830
 A HTG+OHT 104 (16.4) 89 (16.4) 0.00 0.9970
rs2796821 T HTG 147 (27.8) 144 (26.2) 0.38 0.5396
 T OHT 33 (30.0) 144 (26,2) 0.68 0.4093
 T HTG+OHT 180 (28.2) 144 (26.2) 0.61 0.4331
rs1342586 C HTG 106 (20.0) 125 (22.8) 1.26 0.2609
 C OHT 19 (17.3) 125 (22.8) 1.64 0.1999
 C HTG+OHT 125 (19.5) 125 (22.8) 1.91 0.1669
rs2798631 G HTG 255 (48.7) 267 (48.9) 0.01 0.9382
 G OHT 55 (50.0) 267 (48.9) 0.04 0.8334
 G HTG+OHT 310 (48.9) 267 (48.9) 0.00 0.9986
rs1473526 C HTG 138 (26.1) 150 (27.3) 0.18 0.6734
 C OHT 26 (23.6) 150 (27.3) 0.62 0.4311
 C HTG+OHT 64 (25.7) 150 (27.3) 0.37 0.5413
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case white British adults) and not other ethnicities and it would
need to be confirmed if other ethnic groups showed the same
results.
One of the limitations of this study is the absence of CCT
measurement. In the current study, IOP measurements were
checked by a Tono-Pen which is less affected by CCT [46],
in addition to performing applanation tonometry. Two recent
studies that adjusted IOP for CCT found that the correction
did not alter the diagnosis of HTG or NTG [47], and did not
affect the relationship between the prevalence of POAG and
IOP respectively [48]. Furthermore, to be certain that the
participants were correctly assigned to the appropriate case
groups, individuals with borderline IOPs (21–23 mmHg) were
excluded from this study. Even if a correction formulae were
TABLE 2. CONTINUED
B
Block Haplotype All subjects (%) Case (%) Control (%) χ2 p-value
1
(tSNPs 1 to 4) GAGC 42.2 42.9 41.6 0.19 0.6657
 TAGC 18.8 17.3 20.2 1.56 0.2112
 TAGA 18.3 19.1 17.5 0.49 0.4841
 GAAC 14.2 13.4 15.1 0.67 0.4123
 TGGA 6.5 7.4 5.6 1.39 0.2379
2
(tSNPs 8 to 11) TCAA 40.1 40.1 40.1 0.00 0.9891
 CCAA 28.4 28.3 28.5 0.01 0.9386
 CTCG 21.5 21.2 21.9 0.08 0.7746
 CTCA 6.0 6.3 5.7 0.20 0.6592
 CCCA 3.0 2.9 3.2 0.10 0.7473
3
(tSNPs 14 to 15) TG 77.4 76.5 78.3 0.47 0.4950
 CA 16.2 16.0 16.5 0.05 0.8175
 CG 6.3 7.5 5.2 2.32 0.1280
4
(tSNPs 17 to 19) CAT 51.1 51.1 51.1 0.00 0.9927
 CGT 22.1 22.7 21.5 0.21 0.6462
 TGC 21.2 19.8 22.6 1.28 0.2581
 CGC 5.5 6.2 4.7 1.16 0.2809
C
Block Haplotype All subjects (%) Case (%) Control (%) χ2 p-Value
1
(tSNPs 1 to 4) GAGC 42.9 44.0 41.6 0.70 0.4035
 TAGC 18.6 17.1 20.3 1.92 0.1664
 TAGA 17.8 18.1 17.4 0.10 0.7500
 GAAC 14.3 13.7 15.1 0.48 0.4866
 TGGA 6.3 6.9 5.6 0.82 0.3659
2
(tSNPs 8 to 11) TCAA 39.8 39.6 40.1 0.03 0.8680
 CCAA 28.7 28.8 28.5 0.01 0.9220
 CTCG 21.4 20.9 21.9 0.15 0.6992
 CTCA 6.0 6.3 5.7 0.22 0.6401
 CCCA 3.2 3.1 3.2 0.00 0.9491
3
(tSNPs 14 to 15) TG 76.9 75.7 78.3 1.08 0.2979
 CA 16.4 16.4 16.5 0.00 0.9485
 CG 6.7 7.9 5.2 3.44 0.0636
4
(tSNPs 17 to 19) CAT 51.0 50.9 51.1 0.01 0.9415
 CGT 22.5 23.3 21.5 0.54 0.4606
 TGC 20.9 19.4 22.6 1.89 0.1691
 CGC 5.6 6.3 4.7 1.29 0.2556
        A: Distribution of TGFβ2 tSNPs between HTG, OHT and HTG+OHT, compared to the wild type control group. B: Distribution
        of TGFβ2 haplotypes showing no significant associations between HTG cases and controls. C: Distribution of TGFβ2 haplotypes
        showing no significant associations between HTG+OHT cases and controls.
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to be applied with a 10 µm change in the corneal thickness
inducing a 0.2 mmHg change in IOP reading [49], a 2–
3 mmHg IOP change (which would include the excluded
individuals within the borderline IOP) would induce a 100–
150 µm change in the CCT, which is a considerable amount.
Hence, it is still highly unlikely that the individuals with IOPs
of 20 mmHg or below or IOPs of 24 mmHg or higher would
have their diagnosis altered (assuming that the average CCT
is approximately 537–550 µm) [50] since these subjects
would be required to have either an abnormally thin corneas
or an unusually thick corneas.
In summary, this study did not demonstrate any
significant allelic or haplotype associations between TGFβ2,
BMP4, and FOXC1 and OHT/POAG. It is hence concluded
that common variants in the TGFβ2, BMP4, and FOXC1 genes
TABLE 3. NO SIGNIFICANT ASSOCIATIONS IDENTIFIED BETWEEN BMP4 SNPS AND HAPLOTYPES AND POAG EXCEPT BETWEEN THE COMBINED GROUP HTG
+OHT AND BMP4 WHERE THERE WAS A WEAK ASSOCIATION.
A
SNP ID Allele Phenotype Case counts (%) Control counts
(%)
χ2 Uncorrected p-
value
rs11623717 A HTG 197 (62.4) 219 (60.0) 0.63 0.4264
 A OHT 68 (61.8) 329 (60.0) 0.12 0,7274
 A HTG+OHT 395 (62.3) 329 (60.0) 0.64 0.4251
rs17563 A HTG 315 (61.5) 298 (58.0) 1.34 0.2467
 A OHT 60 (60.0) 298 (58.0) 0.14 0.7073
 A HTG+OHT 375 (61.3) 298 (58.0) 1.26 0.2610
rs2761884 T HTG 265 (50.2) 243 (44.3) 3.69 0.0548
 T OHT 56 (50.9) 243 (44.3) 1.59 0.2069
 T HTG+OHT 321 (50.3) 243 (44.3) 4.21 0.0401
rs8014071 C HTG 342 (64.8) 344 (63.0) 0.36 0.5463
 C OHT 74 (67.3) 344 (63.0) 0.72 0.3956
 C HTG+OHT 416 (65.2) 344 (63.0) 0.62 0.4312
rs8014363 A HTG 248 (49.6) 235 (47.6) 0.41 0.5222
 A OHT 52 (48.1) 235 (47.6) 0.01 0.9134
 A HTG+OHT 300 (49.3) 235 (47.6) 0.34 0.5585
B
Block Haplotype All subjects (%) Case Counts (%) Control Counts
(%)
χ2 p-Value
1
(tSNP 1 to 2) AA 57.9 59.1 56.9 0.53 0.4652
 GG 37.1 35.3 38.9 1.47 0.2255
 AG 3.2 3.2 3.2 0.00 0.9555
 GA 1.7 2.4 1.1 2.73 0.0985
2
(tSNP 3 to 5) TCA 46.1 48.0 44.3 1.55 0.2131
 GTG 35.6 34.2 36.9 0.87 0.3506
 GCG 14.9 13.8 5.9 0.92 0.3389
 GCA 2.2 1.6 2.8 1.86 0.1722
C
Block Haplotype All subjects (%) Case counts (%) Control counts
(%)
χ2 p-Value
1
(tSNP 1 to 2) AA 58.1 59.2 56.9 0.63 0.4270
 GG 37.0 35.5 38.9 1.47 0.2252
 AG 3.1 3.1 3.2 0.01 0.9151
 GA 1.7 2.3 1.1 2.62 0.1055
2
(tSNP 3 to 5) TCA 46.2 47.9 44.2 1.58 0.2084
 GTG 35.2 33.8 36.9 1.29 0.2565
 GCG 15.0 14.3 15.9 0.62 0.4322
        A: Distribution of BMP4 tSNPs between HTG, OHT and HTG+OHT, compared to the wild type control group. tSNPs that are
        significantly distributed (p<0.05) are high lighted in bold. B: Distribution of BMP4 haplotypes showing no significant
        associations between HTG cases and controls. C: Distribution of BMP4 haplotypes showing no significant associations between
        HTG+OHT cases and controls.
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do not play a major role in the genetic etiology of POAG in
the population investigated.
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Appendix 1. Primer information.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
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